J. Randall Hoggle, RPh, DPh. With 30 years leadership experience in the pharmaceutical and medical devices industries, has worked in all aspects of the pharmaceutical business. Presently serves as Chairman of the Board, Verax Research Services, Inc., headquartered on Johns Hopkins University's Rockville, MD campus. Previously worked from 2001-2017 as Founding CEO/Chairman of Health Pathways, Inc., in Gaithersburg, MD, which functions as a holding company for six life sciences companies it started or acquired. In earlier years, held various CEO/ Executive roles at companies supported by private or public equity that were successfully sold, including MedContrax, Inc., acquired by NeoForma, Inc [NEOF]; Capital Returns, Inc., acquired by FedEx [FDX]; Racal Health and Safety, Inc., acquired by 3M [MMM]; and Boehringer Mannheim acquired by Hoffman LaRoche [RHHBY]. Graduated Presbyterian College, Clinton SC, BS; Duke University, Durham NC, MBA; and University of Oklahoma, Oklahoma City OK, Doctor of Pharmacy.
